SIOG 2024: Updates in medical oncology
SIOG 2024: Updates in medical oncology
ESMO 2024: Highlights and analysis
The combination of regorafenib, nivolumab and SCRT shows promising efficacy as neoadjuvant therapy for locally advanced RC
Transoral surgery and neck dissection with deintensified risk-based post-operative management increases efficacy in oropharynx cancer
2 year recurrence free survival benefit for resectable melanoma treated with neoadjuvant/adjuvant pembrolizumab
Active surveillance for oesophageal cancer shows improved HRQoL compared to standard surgery
Management of surgical complications in thyroid surgery
Short-course radiation as effective as standard treatment for breast cancer patients choosing reconstruction after mastectomy
IORT at hospital Del Mar Barcelona in Spain